There was a lot of hype about an American company's announcement about ancient dire wolves. It raises questions about the bid ...

The sci-fi fairytale of de-extinction may become a reality. Colossal Laboratories and Biosciences announced they have revived ...

Assembly Biosciences (ASMB) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces ...

A company recently claimed it revived an extinct species, launching a debate across scientific and conservation communities.

Earnings Estimate Revisions for Forte Biosciences For the fiscal year ending December 2024, this company is expected to earn -$21.75 per share, which is a change of 13% from the year-ago reported ...

Given the way analysts feel about Neurocrine Biosciences right now, this huge implied volatility could mean there’s a trade ...

FRAMINGHAM, MA / ACCESS Newswire / April 9, 2025 / Xenetic Biosciences, Inc. (NASDAQ ... constitute forward-looking statements within the meaning of the federal securities laws.

Dr. Reid Bissonnette, Executive Consultant for Translational Research and Development at Xenetic, discusses positive preclinical data recently presented at the Society for Immunotherapy of Cancer ...

About Xenetic Biosciences Xenetic Biosciences ... historical facts may constitute forward-looking statements within the meaning of the federal securities laws. These statements can be identified ...

FRAMINGHAM, MA / ACCESS Newswire / April 9, 2025 / Xenetic Biosciences, Inc. (NASDAQ ... of historical facts may constitute forward-looking statements within the meaning of the federal securities laws ...